NextGen, Medline integrate technologies

Editorial Staff | | Health Exec | EMR/EHR

NextGen Healthcare Information Systems, a wholly owned subsidiary of Quality Systems has entered into a strategic agreement with Medline Industries, a privately held manufacturer and distributor of healthcare products to hospitals, extended care facilities, surgery centers, physician offices and home care organizations.

Under the agreement, Medline’s medical sales force of more than 1,100 representatives will work with NextGen Healthcare to co-market NextGen technologies to Medline’s customer base comprised of more than 100,000 locations consisting of physician practices and hospitals and other healthcare facilities. Medline also will work with its medical device and productivity partners to encourage them to combine their technologies with NextGen Ambulatory EHR.

The alliance also identified Medline as the "preferred provider" of medical supplies for the NextGen Preferred Provider Advantage purchasing program, which is a value-added service to the NextGen customer base that enables clients to purchase their medical supplies, equipment and pharmaceuticals.

 

Editorial Staff

Related Content

Academic health system working on AI dictation feature for Epic
Gottlieb: Let’s not slap the label ‘medical device’ on AI software that only helps clinicians make care decisions
PHOTO GALLERY: The Epic intergalactic headquarters art collection
AI brings cardiology, neurology teams together to boost care for stroke patients
Best in KLAS: End-users review top health IT systems in the US
More than words: AI takes NLP to the next level to identify signs of heart failure

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.